Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

Affibody molecules are small (7 kDa), non-immunoglobulin scaffold proteins with a potential as targeting agents for radionuclide imaging of cancer. However, high renal re-absorption of Affibody molecules prevents their use for radionuclide therapy with residualizing radiometals. We hypothesized that...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Theranostics
Egile Nagusiak: Honarvar, Hadis, Westerlund, Kristina, Altai, Mohamed, Sandström, Mattias, Orlova, Anna, Tolmachev, Vladimir, Karlström, Amelie Eriksson
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679357/
https://ncbi.nlm.nih.gov/pubmed/26722376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.12766
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak